Who Paid My Doc
Mark Boguniewicz
Allergy Denver, CO Medical Doctor
NPI 1790796555 CMS profile 217821
1400 Jackson St, Denver, CO 80206
General payments
$813,807
Research payments
$88,085
Ownership & investment interest
$0
Research they led as principal investigator
$257,025
Through program year 2025, Mark Boguniewicz of Denver, CO is reported in the CMS Open Payments database as having received $813,807 across 669 general payments and $88,085 in research payments paid to them. Separately, studies naming them as principal investigator received $257,025 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Allergy profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $41,971 | 59 | |
| 2025 | Research | $2,760 | 5 | |
| 2024 | General | $85,977 | 71 | |
| 2024 | Research | $12,414 | 21 | |
| 2023 | General | $109,172 | 76 | |
| 2023 | Research | $11,367 | 27 | |
| 2022 | General | $85,967 | 66 | |
| 2022 | Research | $17,258 | 15 | |
| 2021 | General | $103,513 | 45 | |
| 2021 | Research | $19,229 | 19 | |
| 2020 | General | $100,789 | 58 | |
| 2020 | Research | $15,473 | 17 | |
| 2019 | General | $286,417 | 294 | |
| 2019 | Research | $9,584 | 25 |
Beside peers
- Mark Boguniewicz
- Allergy median
- Middle half of Allergy
- National median
In program year 2025, general payments to Mark Boguniewicz were reported at $41,971. Among 526 Allergy profiles paid that year, the median was $1,143 and the middle half received between $226 and $2,504.
Show as a table
| Year | Mark Boguniewicz | Allergy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $286,417 | $506 | $151–$1,337 | $163 |
| 2020 | $100,789 | $409 | $108–$1,162 | $114 |
| 2021 | $103,513 | $549 | $125–$1,485 | $132 |
| 2022 | $85,967 | $666 | $161–$1,594 | $149 |
| 2023 | $109,172 | $780 | $186–$1,916 | $160 |
| 2024 | $85,977 | $1,031 | $271–$2,196 | $164 |
| 2025 | $41,971 | $1,143 | $226–$2,504 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
798 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy in Colorado
Related records
Allergy in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Allergy
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.